Establishes pluripotent mouse embryonic stem cells for immune disease research, highlighting their potential applications.
We have established mouse embryonic stem cells (mESCs) from the embryos of NOD-scid gamma mice. These mESCs exhibit robust pluripotency and differentiation potential. EB differentiation assays demonstrate significant expression of markers from all three germ layers, and karyotpe analysis confirmed their chromosomal stability. Given the strong differentiation capacity of these mESCs, the cell line established in this study can provide a valuable cellular model for research on immune-related diseases.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: